As of 2025-07-05, the Intrinsic Value of IDEXX Laboratories Inc (IDXX) is 428.16 USD. This IDXX valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 547.01 USD, the upside of IDEXX Laboratories Inc is -21.7%.

The range of the Intrinsic Value is 268.15 - 1,130.96 USD.

Is IDXX undervalued or overvalued?

Based on its market price of 547.01 USD and our intrinsic valuation, IDEXX Laboratories Inc (IDXX) is overvalued by 21.7%.

547.01 USD

Stock Price

428.16 USD

Intrinsic Value

Intrinsic Value Details

IDXX Intrinsic Value - Valuation Summary

	Range	Selected	Upside
a
DCF (Growth Exit 5Y)	268.15 - 1,130.96	428.16	-21.7%
DCF (Growth Exit 10Y)	323.34 - 1,275.43	501.10	-8.4%
DCF (EBITDA Exit 5Y)	282.71 - 447.64	351.97	-35.7%
DCF (EBITDA Exit 10Y)	337.13 - 546.4	423.55	-22.6%
Peter Lynch Fair Value	187.14 - 187.14	187.14	-65.79%
P/E Multiples	362.01 - 546.72	442.64	-19.1%
EV/EBITDA Multiples	216.29 - 417.7	334.21	-38.9%
Earnings Power Value	110.31 - 152.09	131.20	-76.0%
Dividend Discount Model - Stable	143.69 - 793.75	468.72	-14.3%
Dividend Discount Model - Multi Stages	220.04 - 951.78	358.23	-34.5%

IDXX Intrinsic Value - Peers Comparison

	Range	Selected	Upside
a
Edwards Lifesciences Corp	47.51 - 173.27	71.66	-6.7%
Resmed Inc	168.02 - 538.38	251.88	-2.0%
Dexcom Inc	29.19 - 136.33	49.04	-40.9%
Steris plc	169.46 - 711.28	275.65	16.0%
Insulet Corp	63.45 - 297.01	106.67	-64.6%
Zimmer Biomet Holdings Inc	67.83 - 291.62	116.94	24.8%
Varian Medical Systems Inc	33.86 - 64.15	43.14	-75.6%
Baxter International Inc	18.22 - 189.21	41.33	33.3%
Hologic Inc	49.7 - 143.65	73.71	13.8%
Hill-Rom Holdings Inc	103.91 - 311.45	159.24	2.1%

IDXX Intrinsic Value - Key Valuation Metrics

Market Cap (mil)	44,330
Beta	0.71
Outstanding shares (mil)	81
Enterprise Value (mil)	45,106

Market risk premium	5.1%
Cost of Equity	7.35%
Cost of Debt	8.85%
WACC	7.3%